openPR Logo
Press release

Endometrial Ablation Market Market Trends and Key Developments 2024

09-19-2017 08:58 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Endometrial Ablation Market Market Trends and Key Developments

TMR estimates that the global market for endometrial ablation will exhibit a promising CAGR of 5.50% from 2016 to 2024, rising from an opportunity worth US$0.8 bn in 2015 to US$1.3 bn by 2024.

Rising Rate of Incidence of Gynecological Diseases to Drive Market

The market is expected to benefit from a number of factors, which will be seen in its steady growth path over the course of the report’s forecast. The key drivers of the market will be factors such as the vast rise in the global prevalence of gynecological disorders, the easy availability of technologically advanced endometrial ablation devices, and high cost of ablation surgeries. The market will also benefit from the rising population of affluent higher middle-class people, especially across emerging economies in regions such as Asia Pacific and Latin America, and the increased expenditure of the world population on advanced healthcare treatments.

View and Download TOC of Endometrial Ablation Market Research Report@ https://www.transparencymarketresearch.com/report-toc/14318

The increased rate of incidence of gynecological conditions such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, and endometrial and cervical cancers in the past few years has boosted the demand for effective treatments. These factors remain at the helm of the remarkable development achieved by the global endometrial ablation market in the past few years and will continue to lead it towards a healthy growth path in the near future.

Increased Preference to Non-invasive Treatments to Bode Well for Market

Despite having healthy growth prospects in the foreseeable future, the market faces challenges such as issues concerning commercialization in developing and under-developed economies and strict regulatory laws and policies in developed economies. Nevertheless, as the global consumer becomes more educated about the vast benefits of non-invasive treatments, in terms of faster recovery, reduced time in hospitals, and cost of the overall treatment, the market will continue to witness a healthy rise in demand. The vast pool of untapped growth opportunities in emerging economies could also act as a good opportunity for companies aspiring to strengthen their hold on the global endometrial ablation market.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14318

North America to Continue to Command Greater Hold on Global Market

In terms of type of devices, the segment of radiofrequency endometrial ablation devices held the dominant share in market’s overall revenue in. The segment is likely to also continue to lead over the report’s forecast period. Factors such as ease of usage, less duration required for surgery, and cost benefits will continue to bode well for the segment over the forecast period, by the end of which the segment is expected to account for a nearly 58% of the overall market. In terms of geography, the market for endometrial ablation in North America is presently the leading contributor in terms of revenue and is likely to retain the top spot throughout the report’s forecast, thanks to the developed healthcare infrastructure. The regional market is projected to hold a nearly 44% of the overall market by 2024.

The presence of a number of large endometrial ablation enterprises such as Cooper Surgical Inc., Medtronic Plc, Boston Scientific Corp., Ethicon Inc., and Hologic Corp., has rendered the vendor landscape of the global endometrial ablation market highly competitive, observes Transparency Market Research in a recent report. To supersede competitors, companies in the market are focusing on growth strategies such as introduction of technologically advanced products and expansion across new regional markets. Owing to these trends, the market has witnessed a vast rise in collaborations, mergers, and acquisitions, leading to a further intensified level of competition.

Buy Full Endometrial Ablation Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=14318<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometrial Ablation Market Market Trends and Key Developments 2024 here

News-ID: 724965 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Endometrial

Endometrial Biopsy Catheter Market 2022 | Detailed Report
Global Endometrial Biopsy Catheter Market 2022-2028, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5389813 The report provides
Endometrial Ablation Market Future Outlook 2021-2030
The Global Endometrial Ablation Market size is estimated to be USD 0.97 billion in 2019 and is predicted to reach USD 1.71 billion by 2030 with a CAGR of 5.3% from 2020-2030. Endometrial Ablation is a procedure which involves the removal of endometrium, the outer layer of uterus to treat the excessive blood flow during It is one of the mostly used non invasive procedure to treat uterine bleeding, prolong
Endometrial Biopsy Catheter Market Technological Breakthroughs
Perimenopausal and postmenopausal (absence of menstruation for 12 months or longer) women usually come across problems of abnormal uterine bleeding. Endometrial biopsy is a safe and efficient procedure for sampling the endometrium in a patient experiencing abnormal uterine bleeding to diagnose the condition and provide appropriate treatment. An endometrial suction catheter is used to carry out the biopsy. Endometrial biopsy catheters are easy to use, and have diagnostic accuracy which
Endometrial Ablation Market Growth Analysis 2024
TMR estimates that the global market for endometrial ablation will exhibit a promising CAGR of 5.50% from 2016 to 2024, rising from an opportunity worth US$0.8 bn in 2015 to US$1.3 bn by 2024. Rising Rate of Incidence of Gynecological Diseases to Drive Market The market is expected to benefit from a number of factors, which will be seen in its steady growth path over the course of the report’s forecast. The
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world. Download The
Global Endometrial Ablation Market: Radiofrequency Endometrial Ablation Devices …
With the presence of large players, such as Hologic Corp., Boston Scientific Corp., Cooper Surgical Inc., Ethicon Inc., and Medtronic Plc at the global level, the worldwide market for endometrial ablation demonstrates a highly competitive landscape, finds a new research report by Transparency Market Research (TMR). The market players are focusing aggressively on developing their offerings technologically, which is likely to lead to price differentiation, resulting in intense rivalry between these